TechAccel hops in $3.2M round for Lincoln-based ag tech firm

March 9, 2017  |  Meghan LeVota

Photo by Peter Kleinau

Kansas City-based TechAccel is joining an investment round in a Nebraska agriculture tech firm that aims to improve crop yields.

The area venture firm is among a group of investors in Lincoln-based Epicrop Technologies Inc., which raised a total of $3.2 million in its Series A round, which was led by North Forty Ventures. TechAccel — which joined Nelnet, Speedway Properties and Allen & Company as investors — declined to disclose the value of their investment.

TechAccel said in a release that the firm is committed to support scientific advancements such as those produced by Epicrop, which developed an “epigenetic” technology. Epigenetics is the study of changes in organisms caused by modification of gene expression, rather than altering the genetic code.

“We’re excited to have TechAccel in our corner, both as an investor and a research partner advancing our technology,” Epicrop CEO Dr. Michael Fromm said in a release. “Their expertise and support will help Epicrop accelerate its programs demonstrating the enormous potential of epigenetics to increase yields and stress tolerance in a variety of crops.”

Combining epigenetics with agriculture, Epicrop co-founder Dr. Sally Mackenzie created a technology that uses conventional plant breeding techniques with molecular markers, enhancing yield in select plants. Greenhouse trials show that Mackenzie’s technology increased yields and stress tolerance for soybeans, tomatoes and sorghum.

“The pressure is on all of us in agriculture to deliver higher performing plants in the face of challenges like climate change and increasing global demand,” Dr. Mackenzie said in a release. “This technology is a critical step forward in addressing those problems head on.”

In December, TechAccel announced a $250,000 partnership with Donald Danforth Plant Science Center, a St. Louis-based nonprofit research institute. Founded in 2014, TechAccel specializes in ag and animal health technology. The firm invests in, sources and acquires early-stage innovations through collaborations with various institutions.

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged ,
Featured Business
    Featured Founder

      2017 Startups to Watch

        stats here

        Related Posts on Startland News

        Events Preview: Conquer for Good, TEDxUMKC

        By Tommy Felts | February 27, 2017

        There are a plethora of entrepreneurial events hosted in Kansas City on a weekly basis. Whether you’re an entrepreneur, investor, supporter, or curious community member — we recommend these upcoming events for you. Are you hosting a relevant community event? Feel free to add it to the FWD/KC calendar for increased exposure. Once your event…

        Jaguar Land Rover invests in artificial intelligence startup Mycroft

        By Tommy Felts | February 27, 2017

        Mycroft has received a significant boost in horsepower. Only a few weeks after entering 500 Startups, Mycroft has landed a strategic partnership with Jaguar Land Rover. The Kansas City-based artificial intelligence startup is among the first startups to enter the Portland-based Jaguar Land Rover Tech Incubator, which will provide Mycroft with a $110,000 investment and…

        KC-based OYO Fitness closes a historically successful Kickstarter

        By Tommy Felts | February 24, 2017

        To say that OYO Fitness has a successful Kickstarter campaign would be an understatement. The Kansas City-based fitness firm folded up and then crushed its recent crowdfunding effort, which raised a stunning $659,000 for its collapsible and compact exercise device. OYO’s DoubleFlex Black campaign — which snagged pre-orders from 4,200 backers — was the second…

        Survivor, innovator Kim Gandy rewards patients for sticking to treatments

        By Tommy Felts | February 24, 2017

        In her 20 years working as a transplantation clinician, Kim Gandy found it baffling that a seemingly simple problem had such a difficult time finding a solution. Transplant patients consistently struggled to adhere to their health regimens, resulting not only in significant costs for care providers but also death. “We were literally losing patients,” Gandy…